Trial intelligence / Profile preview

Phase II randomized double-blind placebo-controlled study of Penyan Kangning Capsules for chronic pelvic pain due to sequelae of pelvic inflammatory disease

CTR20261622Phase 2Active

Sponsor
Xi'an Shangyikang Pharmaceutical Research Institute
Start
Apr 2026
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Penyan Kangning Capsules in chronic prostatitis (CP), Pelviabdominal infection, sponsored by Xi'an Shangyikang Pharmaceutical Research Institute. Started Apr 2026; status: active.

02

Drugs

Penyan Kangning Capsules
03

Conditions

chronic prostatitis (CP)Pelviabdominal infection

Beyond the preview

Go deeper on CTR20261622.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20261622.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call